Clinical trials: Smallpox, open to volunteers
Complication of Smallpox Vaccination
VA-005 Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or Vaccinia Infection
This is a post-marketing study to verify the clinical benefits of VIGIV [CNJ-016, Vaccinia Immune Globulin Intravenous (Human), sterile solution] in the resolution of complications resulting from smallpox vaccination in eligible…
- Trial name
- NCT01374984
- Testing
- VIGIV
- Volunteers
- 100 people
- Sponsor
- Emergent BioSolutions